Cargando…
Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
OBJECTIVE: This study aims to explore the pathological characteristics of metabolic-related hepatocellular carcinoma (HCC) and its correlation with metabolic factors. METHODS: Fifty-one patients with liver cancer of unknown causes were enrolled. Biopsy of the liver and staining of the liver tissues...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257051/ https://www.ncbi.nlm.nih.gov/pubmed/37304209 http://dx.doi.org/10.2147/JHC.S412129 |
_version_ | 1785057232147185664 |
---|---|
author | Sun, Lei Zhao, Hong Ding, Xiao-Yan Yang, Kun Wang, Gui-Shuang Chen, Jia-Min Han, Xiao-Yi Wan, Gang Zhang, Liang Zhou, Xin-Gang Chen, Xiang-Mei Wang, Peng Xie, Wen |
author_facet | Sun, Lei Zhao, Hong Ding, Xiao-Yan Yang, Kun Wang, Gui-Shuang Chen, Jia-Min Han, Xiao-Yi Wan, Gang Zhang, Liang Zhou, Xin-Gang Chen, Xiang-Mei Wang, Peng Xie, Wen |
author_sort | Sun, Lei |
collection | PubMed |
description | OBJECTIVE: This study aims to explore the pathological characteristics of metabolic-related hepatocellular carcinoma (HCC) and its correlation with metabolic factors. METHODS: Fifty-one patients with liver cancer of unknown causes were enrolled. Biopsy of the liver and staining of the liver tissues with hematoxylin–eosin as well as special and immunohistochemical stains were performed. The histological subtypes of HCC were diagnosed based on the WHO Classification of Malignant Hepatocellular Tumors. The NAFLD activity score system was adopted for assessing the surrounding non-neoplastic liver tissues. RESULTS: Of the total, 42 (82.4%) patients were diagnosed with HCC, 32 had metabolic risk factors, 20 patients met the diagnostic criteria of the metabolic-associated fatty liver disease (MAFLD)-related HCC, and 40.6% (13/32) had liver cirrhosis. The incidence of cirrhosis (p = 0.033) and diabetes mellitus type 2 (p = 0.036) in patients with MAFLD-related HCC was notably higher than that in HCC patients with only metabolic risk factors. Among the 32 HCC cases with metabolic risk factors, trabecular type was the most prevalent, followed by steatohepatitis type, scirrhous type, solid type, pseudoglandular type, clear-cell type, and macrotrabecular type. The degree of tumor cells’ swelling and ballooning was found to be positively related to the degree of fibrosis in the surrounding liver tissues (p = 0.011) as well as the proportion of cirrhosis (p = 0.004). Moreover, the degree of fibrosis in the surrounding liver tissues showed a negative correlation with the levels of serum cholesterol (p = 0.002), low-density lipoprotein (p = 0.002), ApoA1 (p = 0.009), ApoB (p = 0.022), total protein (p = 0.015), WBC count (p = 0.006), and PLT count (p = 0.015). CONCLUSION: Pathological characteristics of the tumor and adjacent non-neoplastic liver tissues of HCC with metabolic risk factors were found to be correlated with metabolic abnormalities. |
format | Online Article Text |
id | pubmed-10257051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-102570512023-06-11 Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors Sun, Lei Zhao, Hong Ding, Xiao-Yan Yang, Kun Wang, Gui-Shuang Chen, Jia-Min Han, Xiao-Yi Wan, Gang Zhang, Liang Zhou, Xin-Gang Chen, Xiang-Mei Wang, Peng Xie, Wen J Hepatocell Carcinoma Original Research OBJECTIVE: This study aims to explore the pathological characteristics of metabolic-related hepatocellular carcinoma (HCC) and its correlation with metabolic factors. METHODS: Fifty-one patients with liver cancer of unknown causes were enrolled. Biopsy of the liver and staining of the liver tissues with hematoxylin–eosin as well as special and immunohistochemical stains were performed. The histological subtypes of HCC were diagnosed based on the WHO Classification of Malignant Hepatocellular Tumors. The NAFLD activity score system was adopted for assessing the surrounding non-neoplastic liver tissues. RESULTS: Of the total, 42 (82.4%) patients were diagnosed with HCC, 32 had metabolic risk factors, 20 patients met the diagnostic criteria of the metabolic-associated fatty liver disease (MAFLD)-related HCC, and 40.6% (13/32) had liver cirrhosis. The incidence of cirrhosis (p = 0.033) and diabetes mellitus type 2 (p = 0.036) in patients with MAFLD-related HCC was notably higher than that in HCC patients with only metabolic risk factors. Among the 32 HCC cases with metabolic risk factors, trabecular type was the most prevalent, followed by steatohepatitis type, scirrhous type, solid type, pseudoglandular type, clear-cell type, and macrotrabecular type. The degree of tumor cells’ swelling and ballooning was found to be positively related to the degree of fibrosis in the surrounding liver tissues (p = 0.011) as well as the proportion of cirrhosis (p = 0.004). Moreover, the degree of fibrosis in the surrounding liver tissues showed a negative correlation with the levels of serum cholesterol (p = 0.002), low-density lipoprotein (p = 0.002), ApoA1 (p = 0.009), ApoB (p = 0.022), total protein (p = 0.015), WBC count (p = 0.006), and PLT count (p = 0.015). CONCLUSION: Pathological characteristics of the tumor and adjacent non-neoplastic liver tissues of HCC with metabolic risk factors were found to be correlated with metabolic abnormalities. Dove 2023-06-05 /pmc/articles/PMC10257051/ /pubmed/37304209 http://dx.doi.org/10.2147/JHC.S412129 Text en © 2023 Sun et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Sun, Lei Zhao, Hong Ding, Xiao-Yan Yang, Kun Wang, Gui-Shuang Chen, Jia-Min Han, Xiao-Yi Wan, Gang Zhang, Liang Zhou, Xin-Gang Chen, Xiang-Mei Wang, Peng Xie, Wen Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors |
title | Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors |
title_full | Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors |
title_fullStr | Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors |
title_full_unstemmed | Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors |
title_short | Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors |
title_sort | clinicopathological features of hepatocellular carcinoma with metabolic risk factors |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257051/ https://www.ncbi.nlm.nih.gov/pubmed/37304209 http://dx.doi.org/10.2147/JHC.S412129 |
work_keys_str_mv | AT sunlei clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT zhaohong clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT dingxiaoyan clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT yangkun clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT wangguishuang clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT chenjiamin clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT hanxiaoyi clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT wangang clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT zhangliang clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT zhouxingang clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT chenxiangmei clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT wangpeng clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors AT xiewen clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors |